Cite
Dickson MA, D'Adamo DR, Keohan ML, et al. Phase II Trial of Gemcitabine and Docetaxel with Bevacizumab in Soft Tissue Sarcoma. Sarcoma. 2015;2015:532478doi: 10.1155/2015/532478.
Dickson, M. A., D'Adamo, D. R., Keohan, M. L., D'Angelo, S. P., Carvajal, R. D., Gounder, M. M., Maki, R. G., Qin, L. X., Lefkowitz, R. A., McKennon, O. R., Hirst, C. M., Schwartz, G. K., & Tap, W. D. (2015). Phase II Trial of Gemcitabine and Docetaxel with Bevacizumab in Soft Tissue Sarcoma. Sarcoma, 2015532478. https://doi.org/10.1155/2015/532478
Dickson, Mark A, et al. "Phase II Trial of Gemcitabine and Docetaxel with Bevacizumab in Soft Tissue Sarcoma." Sarcoma vol. 2015 (2015): 532478. doi: https://doi.org/10.1155/2015/532478
Dickson MA, D'Adamo DR, Keohan ML, D'Angelo SP, Carvajal RD, Gounder MM, Maki RG, Qin LX, Lefkowitz RA, McKennon OR, Hirst CM, Schwartz GK, Tap WD. Phase II Trial of Gemcitabine and Docetaxel with Bevacizumab in Soft Tissue Sarcoma. Sarcoma. 2015;2015:532478. doi: 10.1155/2015/532478. Epub 2015 May 14. PMID: 26074722; PMCID: PMC4446476.
Copy
Download .nbib